US Tariffs on Indian Medicines
President Donald Trump has proposed 200% US tariffs on Indian medicines. However, imports of generic drugs have faced higher tariffs.
Moreover, industry experts say the long-term impacts may be transitory.
Additionally, India’s cost advantage and America’s dependence on imported generics can push America to import medicines from India.
The generic drugs entering the US would face zero tariffs for two years.
After this, the levy would rise to 100% for a year, then to 200% thereafter.
In addition, the US imported $213 billion worth of pharmaceutical medicines and drugs in 2025.
Furthermore, America is market.
Impact of US tariffs on India's pharmaceutical Industry
As part of a strategy, industry experts predict a phased Impact of US tariffs on India’s pharmaceutical industry. In a nutshell, India supplies about 47% of US generic prescriptions.
Above all, the crucial takeaway is that there will be 0% immediate tariffs until August 01, 2028.
Thereafter, there will be 100% tariffs in August 2028 and 200% tariffs in August 2029.
Thus, it gives Indian pharma companies around two years to change their manufacturing and supply strategies.
On top of this, the final decision will depend on whether the tariffs cover only finished medicines.
After this, this may also include active pharmaceutical ingredients and other pharmaceutical inputs.
➡ If wanted to know more about : How are India’s pharma exports thriving in new markets in Brazil; click here ⬅
Conclusion
The U.S’. phased tariff roadmap on generic drugs gives Indian manufacturers a two-year grace period at 0% tariff through July 2028. Most importantly, it will follow a 100% tariff until August 2029 and 200% thereafter. In conclusion, this policy aims to force reshoring, but it threatens higher drug costs for Americans and forces Indian firms to weigh expensive U.S. facility investments. Additionally, industry leaders conclude that steep duties will ultimately drive prescription medicine expenses for U.S. patients due to the high operational costs of American production.
Falcon Freight can help pharmaceutical exporters by optimising customs clearance, and managing global supply chain shifts. We can also provide strategic freight forwarding during the US tariff transition period.
For more information:
Phone No. :- +91 9311595648.
Email :- cargodeal@falconfreight.com